Studies of pathogenesis, prognostic factors and treatment in gynecologic cancer.
- Prosjektnummer
- 911351
- Ansvarlig person
- Helga B Salvesen
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Cancer
- Forskningsaktivitet
- 5. Treatment Developement
CDR2 antigen and Yo antibodies.
Cancer Immunol Immunother 2011 Feb;60(2):283-9. Epub 2010 nov 16
PMID: 21080165
Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer.
Histopathology 2010 Oct;57(4):641-6.
PMID: 20955391
Prognostic impact of parity in 493 uterine sarcoma patients.
Int J Gynecol Cancer 2009 Aug;19(6):1062-7.
PMID: 19820369
Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting.
Am J Obstet Gynecol 2009 Dec;201(6):603.e1-7. Epub 2009 okt 3
PMID: 19800606
Biologic markers in endometrial cancer treatment.
APMIS 2009 Oct;117(10):693-707.
PMID: 19775337
Somatic mutations are present in all members of the AKT family in endometrial carcinoma.
Br J Cancer 2009 Oct;101(7):1218-9; author reply 1220-1. Epub 2009 sep 8
PMID: 19738612
Plasma calprotectin concentrations in women with endometrial carcinoma.
Gynecol Oncol 2009 Sep;114(3):491-5. Epub 2009 jul 3
PMID: 19577278
Parity and time interval since childbirth influence survival in endometrial cancer patients.
Int J Gynecol Cancer 2009 May;19(4):665-9.
PMID: 19509568
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Proc Natl Acad Sci U S A 2009 Mar;106(12):4834-9. Epub 2009 mar 4
PMID: 19261849
Onconeural antibodies in sera from patients with various types of tumours.
Cancer Immunol Immunother 2009 Nov;58(11):1795-800. Epub 2009 mar 18
PMID: 19294382
Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma.
Histopathology 2009 Jan;54(2):174-83.
PMID: 19207942
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.
Clin Cancer Res 2009 Feb;15(4):1417-27. Epub 2009 feb 3
PMID: 19193619
Endometrial cancer state of the science meeting.
Int J Gynecol Cancer 2009 Jan;19(1):134-40.
PMID: 19258955
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
N Engl J Med 2008 Nov;359(19):1995-2004. Epub 2008 okt 15
PMID: 18923165
GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival.
Am J Obstet Gynecol 2008 Nov;199(5):543.e1-7. Epub 2008 jul 3
PMID: 18599012
Drug-sensitive FGFR2 mutations in endometrial carcinoma.
Proc Natl Acad Sci U S A 2008 Jun;105(25):8713-7. Epub 2008 jun 13
PMID: 18552176
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
Br J Cancer 2008 May;98(10):1662-9. Epub 2008 mai 13
PMID: 18475299
HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas.
Int J Oncol 2008 Feb;32(2):307-16.
PMID: 18202752
Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization.
Anal Biochem 2007 Jul;366(1):46-58. Epub 2007 mar 18
PMID: 17449007
Gene expression signature characterized by PI3Kinase activation validates to identify aggressive disease in endometrial cancer.
Oral presentation IGCS biannual meeting Prague 2010
STATHMIN OVEREXPRESSION IDENTIFIES HIGH RISK PATIENTS AND LYMPH NODE METASTASIS IN ENDOMETRIAL CANCER.
Oral presentation IGCS biannual meeting Prague 2010.
HORMONE RECEPTOR STATUS IN ENDOMETRIAL CARCINOMA CURETTAGE INDEPENDENTLY PREDICT LYMPH NODE METASTASES AND PROGNOSIS.
Oral presentation IGCS biannual meeting Prague 2010.
High BMI is significantly associated with positive progesterone receptor status and clinico-pathologic markers.
IGCS biannual meeting 2010.
Discovery of somatic mutations in endometrial cancer
AACR 2007 #2946
Patterns of gene expression related to vascular invasion and aggressive features in endometrial cancer
AACR #4703
HER-2/neu expression is associated with increased tumor cell proliferation, loss of hormone receptors and an aggressive phenotyp
AACR #5040
Biologic and prognostic markers in endometrial carcinoma. A study with special focus on tumor markers in curettage specimens.
- Disputert:
- juni 2008
- Hovedveileder:
- Helga Salvesen
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest